Insider · CIK 0001940272
ADAR1 Capital Management, LLC
owner
Files at TENX (TENAX THERAPEUTICS, INC.), KROS (Keros Therapeutics, Inc.), INM (InMed Pharmaceuticals Inc.). First filing Apr 11, 2025, latest Oct 8, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
6 / 0
$13M bought, $0 sold
Where the trades landed
Last year at the 3 companies this insider has traded most, with each buy and sell on the bar it happened.
INM: InMed Pharmaceuticals Inc.
INMOct 9, 2026 · close 1.36
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
TENX: TENAX THERAPEUTICS, INC.
TENXOct 9, 2026 · close 1.87
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
KROS: Keros Therapeutics, Inc.
KROSOct 9, 2026 · close 11.95
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 12Weak | INMbuy InMed Pharmaceuticals Inc. | $14k 10,903 shares | +1% | - | |
| 19Weak | INMbuy InMed Pharmaceuticals Inc. | $57k 42,920 shares | +5% | - | |
| 20Weak | INMbuy InMed Pharmaceuticals Inc. | $118k 91,101 shares | +11% | - | |
| 55Moderate | TENAX THERAPEUTICS, INC. | $1.6M 900,000 shares | +16% | - | |
| 50Moderate | TENAX THERAPEUTICS, INC. | $1.4M 770,333 shares | +16% | - | |
| 38Weak | KROSbuy Keros Therapeutics, Inc. | $9.5M 934,258 shares | +27% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | INM InMed Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: See Footnote | +5,601 | $1.33 | $7,436 | 940,622 | 4 d ago |
| Oct 7, 2026 | INM InMed Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: See Footnote | +3,046 | $1.33 | $4,051 | 943,668 | 4 d ago |
| Oct 8, 2026 | INM InMed Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: See Footnote | +2,256 | $1.33 | $2,997 | 945,924 | 4 d ago |
| Oct 1, 2026 | INM InMed Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: See Footnote | +16,431 | $1.33 | $22k | 908,532 | 7 d ago |
| Oct 2, 2026 | INM InMed Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: See Footnote | +8,307 | $1.33 | $11k | 916,839 | 7 d ago |
| Oct 5, 2026 | INM InMed Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: See Footnote | +18,182 | $1.33 | $24k | 935,021 | 7 d ago |
| Sep 14, 2026 | INM InMed Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: See Footnote | +28,505 | $1.29 | $37k | 829,505 | 26 d ago |
| Sep 15, 2026 | INM InMed Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: See Footnote | +54,256 | $1.30 | $70k | 883,761 | 26 d ago |
| Sep 16, 2026 | INM InMed Pharmaceuticals Inc. | POpen-market purchase Common Sharesindirect: See Footnote | +8,340 | $1.29 | $11k | 892,101 | 26 d ago |
| Sep 3, 2026 | TENX TENAX THERAPEUTICS, INC. | POpen-market purchase Common Stockindirect: See Footnote | +900,000 | $1.78 | $1.6M | 6,524,151 | 34 d ago |
| Aug 31, 2026 | TENX TENAX THERAPEUTICS, INC. | POpen-market purchase Common Stockindirect: See Footnote | +403,571 | $1.79 | $723k | 5,257,389 | 40 d ago |
| Sep 1, 2026 | TENX TENAX THERAPEUTICS, INC. | POpen-market purchase Common Stockindirect: See Footnote | +179,058 | $1.80 | $322k | 5,436,447 | 40 d ago |
| Sep 2, 2026 | TENX TENAX THERAPEUTICS, INC. | POpen-market purchase Common Stockindirect: See Footnote | +187,704 | $1.80 | $338k | 5,624,151 | 40 d ago |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | XIn-the-money exercise Common Stockindirect: By ADAR1 Partners, LP | -100 | $60.00 | $6,000 | 4,392,637 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | XIn-the-money exercise Common Stockindirect: By ADAR1 Partners, LP | -1,400 | $70.00 | $98k | 4,391,237 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | XIn-the-money exercise Common Stockindirect: By Spearhead Insurance Solutions IDF, LLC | -200 | $70.00 | $14k | 743,358 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | XIn-the-money exercise Put Option (right to sell)derivativeindirect: By ADAR1 Partners, LP | -1 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | XIn-the-money exercise Put Option (right to sell)derivativeindirect: By ADAR1 Partners, LP | -14 | $0.00 | $0 | 0 | Jun 24, 2025 |
| Jun 20, 2025 | KROS Keros Therapeutics, Inc. | XIn-the-money exercise Put Option (right to sell)derivativeindirect: By Spearhead Insurance Solutions IDF, LLC | -2 | $0.00 | $0 | 0 | Jun 24, 2025 |
| May 16, 2025 | KROS Keros Therapeutics, Inc. | EExpiration of short derivative Put Option (obligation to buy)derivativeindirect: By ADAR1 Partners, LP | -300 | $0.00 | $0 | 0 | Jun 12, 2025 |
| May 16, 2025 | KROS Keros Therapeutics, Inc. | EExpiration of short derivative Put Option (obligation to buy)derivativeindirect: By ADAR1 Partners, LP | -836 | $0.00 | $0 | 0 | Jun 12, 2025 |
| May 16, 2025 | KROS Keros Therapeutics, Inc. | EExpiration of short derivative Put Option (obligation to buy)derivativeindirect: By Spearhead Insurance Solutions IDF, LLC | -178 | $0.00 | $0 | 0 | Jun 12, 2025 |
| Apr 9, 2025 | KROS Keros Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By ADAR1 Partners, LP | +18,560 | $9.40 | $174k | 3,493,404 | Apr 11, 2025 |
| Apr 9, 2025 | KROS Keros Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By Spearhead Insurance Solutions IDF, LLC | +16,365 | $9.40 | $154k | 743,558 | Apr 11, 2025 |
| Apr 9, 2025 | KROS Keros Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By ADAR1 Partners, LP | +325,000 | $9.86 | $3.2M | 3,818,404 | Apr 11, 2025 |
| Apr 9, 2025 | KROS Keros Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By ADAR1 Partners, LP | +500,000 | $10.33 | $5.2M | 4,318,404 | Apr 11, 2025 |
| Apr 9, 2025 | KROS Keros Therapeutics, Inc. | POpen-market purchase Common Stockindirect: By ADAR1 Partners, LP | +74,333 | $10.33 | $768k | 4,392,737 | Apr 11, 2025 |
| Apr 9, 2025 | KROS Keros Therapeutics, Inc. | JOther Cash-Settled Total Return Swapsderivativeindirect: By ADAR1 Partners, LP | -325,000 | - | - | 624,333 | Apr 11, 2025 |
| Apr 9, 2025 | KROS Keros Therapeutics, Inc. | JOther Cash-Settled Total Return Swapsderivativeindirect: By ADAR1 Partners, LP | -500,000 | - | - | 124,333 | Apr 11, 2025 |
| Apr 9, 2025 | KROS Keros Therapeutics, Inc. | JOther Cash Settled Total Return Swapsderivativeindirect: By ADAR1 Partners, LP | -74,333 | - | - | 50,000 | Apr 11, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.